The EMBO Journal Biological sciences
Heterochromatin epimutations impose mitochondrial dysfunction to confer antifungal resistance
Abstract
Heterochromatin-island epimutations can provide resistance to caffeine and antifungal drugs in the fission yeast Schizosaccharomyces pombe . This study reveals that some epimutations cause resistance via a mechanism exploiting mitochondrial dysfunction. Genetic mutations or epimutations at loci encoding mitochondrial proteins LYR domain protein Cup1 and the Cox1 translation regulator Ppr4 cause resistance to caffeine and antifungal drugs. Both genetic mutants and epimutants of cup1 and ppr4 cause mitochondrial dysfunction, respiratory deficiency, poor growth on non-glucose carbon sources, and elevated reactive oxygen species. Deficiency in Cup1 or Ppr4 activates the Pap1 transcription factor-dependent oxidative stress response pathway and the mitonuclear retrograde pathway. Pap1 is recruited to promoters of genes encoding oxidoreductases and membrane transporters, causing increased efflux activity. Thus, mitochondrial dysfunction phenotypes and increased efflux explain how heterochromatin-island epimutations cause drug resistance. Epimutations in S. pombe genomic regions encoding mitochondrial proteins Ppr4 or Cup1 lead to antifungal resistance via mitochondrial dysfunction, oxidative stress and increased efflux. Antifungal resistance in pathogenic fungi endanger global health and food supply. Wild-type fission yeast, Schizosaccharomyces pombe , can gain resistance to insults including caffeine and antifungal compounds through reversible epimutations. Resistant epimutants exhibit ectopic histone-H3K9 methylation-dependent heterochromatin islands, repressing underlying genes. Two genes whose heterochromatin island-induced repression causes resistance encode mitochondrial proteins: LYR-domain protein Cup1 and Cox1 translation regulator Ppr4. Genetic mutations, cup1-tt and ppr4Δ , that phenocopy epimutants, cause mitochondrial dysfunction, including respiratory deficiency, poor growth on non-glucose carbon sources, and elevated reactive oxygen species. Transcriptomic analyses indicate cup1-tt and ppr4Δ cells activate Pap1 transcription factor-dependent oxidative stress response and mitonuclear retrograde pathways. Pap1 nuclear localisation and recruitment to promoters of oxidoreductase and membrane transporter genes is increased, causing increased efflux activity. cup1 and ppr4 epimutants likewise show mitochondrial dysfunction phenotypes and increased efflux, explaining how heterochromatin-island epimutations cause drug resistance. Thus, wild-type cells harness epimutations that impose mitochondrial dysfunction to bypass external insults. As mitochondrial dysfunction is linked to antifungal resistance in several fungi, similar epimutations likely contribute to development of resistance in fungal pathogens.